# Astragaloside IV Alleviates Trueperella pyogenes-Induced Endometritis via the Nrf2/HO-1 Signaling Pathway

**Authors:** Chunyang Gou, Hetian Mu, Yueting Wang, Yanan Liu, Ziqi Peng, Yun Li, Mingwei Xing, Maozhen Qi

PMC · DOI: 10.3390/antiox15020271 · Antioxidants · 2026-02-22

## TL;DR

Astragaloside IV, a compound from traditional Chinese medicine, protects against endometritis caused by T. pyogenes by reducing inflammation and oxidative stress through the Nrf2/HO-1 pathway.

## Contribution

This study is the first to demonstrate that Astragaloside IV alleviates T. pyogenes-induced endometritis via the Nrf2/HO-1 signaling pathway.

## Key findings

- AS-IV reduces T. pyogenes-induced endometrial damage by suppressing inflammation, apoptosis, and oxidative stress.
- Transcriptomic analysis shows AS-IV's effects are linked to inflammation, apoptosis, and oxidative stress pathways.
- Nrf2 and HO-1 mediate the protective effects of AS-IV, confirmed by Nrf2 inhibition experiments.

## Abstract

The increasing antimicrobial resistance of T. pyogenes, one of the principal pathogens associated with endometritis, presents a formidable challenge in veterinary medicine. Astragaloside IV (AS-IV) is a triterpene saponin compound isolated from the traditional Chinese medicine Astragalus membranaceus. While recognized as the primary bioactive constituent of Astragalus membranaceus with diverse pharmacological properties, its potential to counteract T. pyogenes-induced endometritis has yet to be elucidated. In the current study, T. pyogenes infection models were successfully established in both mouse uteri and cultured goat endometrial epithelial cells (gEECs). Integrating histopathology, molecular biology and transcriptomic technology, this study characterized the multifaceted biological effects of AS-IV. Transcriptomic analysis indicates that the regulatory effects of AS-IV on T. pyogenes-induced infection are primarily associated with the enrichment of signaling pathways related to inflammation, apoptosis, and oxidative stress. Subsequent validation demonstrated that AS-IV treatment effectively alleviated T. pyogenes-induced endometrial damage by suppressing inflammation, apoptosis, and oxidative stress. These effects were mediated through Nrf2 and its downstream target HO-1, a mechanism further confirmed by the loss of protection upon Nrf2 inhibition. In summary, AS-IV protects the endometrium against T. pyogenes-induced inflammatory and oxidative damage by activating the Nrf2/HO-1 signaling pathway.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], HMOX1 (heme oxygenase 1) [NCBI Gene 3162]
- **Chemicals:** Astragaloside IV (PubChem CID 158694)
- **Diseases:** endometritis (MONDO:0000918)
- **Species:** Astragalus membranaceus (taxon 649199), Mus musculus (taxon 10090), Capra hircus (taxon 9925)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Irf9 (interferon regulatory factor 9) [NCBI Gene 16391] {aka Irf-9, Isgf3g, p48}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, HMOX1 (heme oxygenase 1) [NCBI Gene 513221] {aka HO-1}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 12767] {aka CD184, CXC-R4, CXCR-4, Cmkar4, LESTR, PB-CKR}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 497024] {aka NRF2}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Bax (BCL2-associated X protein) [NCBI Gene 12028], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Casp9 (caspase 9) [NCBI Gene 12371] {aka APAF-3, CASP-9, Caspase-9, ICE-LAP6, Mch6}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, TERT (telomerase reverse transcriptase) [NCBI Gene 518884], Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Casp8 (caspase 8) [NCBI Gene 12370] {aka CASP-8, FLICE, MACH, Mch5}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, Ccl17 (C-C motif chemokine ligand 17) [NCBI Gene 20295] {aka Abcd-2, Scya17, Scya17l, Tarc}, NEU1 (neuraminidase 1) [NCBI Gene 505554], Ticam1 (TIR domain containing adaptor molecule 1) [NCBI Gene 106759] {aka TICAM-1, TRIF}, Gdf15 (growth differentiation factor 15) [NCBI Gene 23886] {aka MIC-1, NAG-1, SBF}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Hk (hook) [NCBI Gene 109541], Bnip3 (BCL2/adenovirus E1B interacting protein 3) [NCBI Gene 12176] {aka Nip3}, Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** mastitis (MESH:D008413), Endometritis (MESH:D004716), pneumonia (MESH:D011014), hyperemia (MESH:D006940), organ injury (MESH:D009102), hemorrhage (MESH:D006470), edema (MESH:D004487), injury to (MESH:D014947), Inflammation (MESH:D007249), infectious (MESH:D003141), necrosis (MESH:D009336), immune dysregulation (OMIM:614878), hepatic, renal, and cardiac diseases (MESH:D006331), Endometrial Damage (MESH:D014591), bacterial infection (MESH:D001424), T. pyogenes (MESH:D001260), abortion (MESH:D000026), Infection (MESH:D007239), T. pyogenes (MESH:D017789), gEECs (MESH:D009375), heavy metal toxicity (MESH:D000075322)
- **Chemicals:** poly-T (MESH:D011071), cholesterol (MESH:D002784), gentamicin (MESH:D005839), SDS (MESH:D012967), alkaloids (MESH:D000470), DCF (MESH:C037631), TRIzol (MESH:C411644), nicotinamide (MESH:D009536), CCK-8 (MESH:D012844), lipid peroxides (MESH:D008054), lincosamides (MESH:D055231), streptomycin (MESH:D013307), EDTA (MESH:D004492), FITC (MESH:D016650), paraffin (MESH:D010232), LNT (MESH:D007912), ROS (MESH:D017382), glycosides (MESH:D006027), flavonoids (MESH:D005419), PVDF (MESH:C024865), Eosin (MESH:D004801), AS-IV (MESH:C052064), LPS (MESH:D008070), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), CO2 (MESH:D002245), ATP (MESH:D000255), MDA (MESH:D008315), macrolides (MESH:D018942), PMSF (MESH:D010664), tetracycline (MESH:D013752), penicillin (MESH:D010406), Hematoxylin (MESH:D006416), H&amp;E (MESH:D006371), Chinese medicine (-)
- **Species:** Astragalus membranaceus (species) [taxon 649199], Mus musculus (house mouse, species) [taxon 10090], Metamycoplasma hominis (species) [taxon 2098], Escherichia coli (E. coli, species) [taxon 562], Trueperella pyogenes (species) [taxon 1661], Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606], Staphylococcus (genus) [taxon 1279]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937940/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937940/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937940/full.md

---
Source: https://tomesphere.com/paper/PMC12937940